Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results
| Autor: | Chitra Hosing, Christina Chancoco, Stefan O. Ciurea, Amin M. Alousi, Issa F. Khouri, Celina Ledesma, Anas Younes, Richard E. Champlin, Rima M. Saliba, Yago Nieto, Uday R. Popat, Michelle A. Fanale, Rosamar Valverde, Sandra Acholonu, Paolo Anderlini, Elizabeth J. Shpall |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Oncology
Melphalan Cancer Research medicine.medical_specialty business.industry Hematology medicine.disease Gemcitabine Surgery Fludarabine Regimen surgical procedures operative immune system diseases hemic and lymphatic diseases Internal medicine medicine Refractory Hodgkin Lymphoma Transplantation Conditioning Stem cell business Progressive disease medicine.drug |
| Zdroj: | Leukemia & Lymphoma. 53:499-502 |
| ISSN: | 1029-2403 1042-8194 |
| Popis: | Progressive disease (PD) remains the main cause of treatment failure following reduced-intensity conditioning (RIC) allogeneic stem cell transplant (allo-SCT) in Hodgkin lymphoma (HL) [1]. The dise... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|